Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Health services research in the public healthcare system in Hong Kong: An analysis of over 1 million antihypertensive prescriptions between 2004–2007 as an example of the potential and pitfalls of using routinely collected electronic patient data

  • Martin CS Wong1,
  • Johnny Y Jiang1,
  • Jin-ling Tang1,
  • Augustine Lam1,
  • Hong Fung1 and
  • Stewart W Mercer2Email author
BMC Health Services Research20088:138

https://doi.org/10.1186/1472-6963-8-138

Received: 14 November 2007

Accepted: 25 June 2008

Published: 25 June 2008

Abstract

Background

Increasing use is being made of routinely collected electronic patient data in health services research. The aim of the present study was to evaluate the potential usefulness of a comprehensive database used routinely in the public healthcare system in Hong Kong, using antihypertensive drug prescriptions in primary care as an example.

Methods

Data on antihypertensive drug prescriptions were retrieved from the electronic Clinical Management System (e-CMS) of all primary care clinics run by the Health Authority (HA) in the New Territory East (NTE) cluster of Hong Kong between January 2004 and June 2007. Information was also retrieved on patients' demographic and socioeconomic characteristics, visit type (new or follow-up), and relevant diseases (International Classification of Primary Care, ICPC codes).

Results

1,096,282 visit episodes were accessed, representing 93,450 patients. Patients' demographic and socio-economic details were recorded in all cases. Prescription details for anti-hypertensive drugs were missing in only 18 patients (0.02%). However, ICPC-code was missing for 36,409 patients (39%). Significant independent predictors of whether disease codes were applied included patient age ≥ 70 years (OR 2.18), female gender (OR 1.20), district of residence (range of ORs in more rural districts; 0.32–0.41), type of clinic (OR in Family Medicine Specialist Clinics; 1.45) and type of visit (OR follow-up visit; 2.39).

In the 57,041 patients with an ICPC-code, uncomplicated hypertension (ICPC K86) was recorded in 45,859 patients (82.1%). The characteristics of these patients were very similar to those of the non-coded group, suggesting that most non-coded patients on antihypertensive drugs are likely to have uncomplicated hypertension.

Conclusion

The e-CMS database of the HA in Hong Kong varies in quality in terms of recorded information. Potential future health services research using demographic and prescription information is highly feasible but for disease-specific research dependant on ICPC codes some caution is warranted. In the case of uncomplicated hypertension, future research on pharmaco-epidemiology (such as prescription patterns) and clinical issues (such as side-effects of medications on metabolic parameters) seems feasible given the large size of the data set and the comparability of coded and non-coded patients.

Background

The use of electronic patient records within healthcare systems has important implications for health services research. When used within a comprehensive computerized data management system such records can support research into the aetiology of disease [1, 2], the predictive value of symptoms in diagnosis [3], the clinical effectiveness and cost effectiveness of interventions [4], and in evaluating whole-system approaches to the organization and delivery of care [5]. The databases invariably contain a large number of subjects, may provide almost complete population coverage (depending on the healthcare and data collection systems), often provide reliable information on variables such as demographic characteristics, prescribing patterns and diagnoses, and in theory allow for quick and efficient data retrieval [6]. Notable examples include the UK General Practice Research Database (GPRD) [7], the Health Search Database in Italy [8], and Ontario Drug Benefit (ODB) database [9]. Some databases include almost all residents of a province [10, 11], thus enhancing the applicability and generalizability of findings.

In many western countries these databases have been constructed in a systematic manner and influential study results have been published [1215]. There is a growing trend for these evolving information systems to implement regional networks [16] and allow physician- or patient- access to clinical information, as well as integration of a broader spectrum of patient data. Hong Kong initiated the operation of a comprehensive computerized recording and management system in the public sector in 2000. All patient information, drug prescription details and laboratory investigation results are routinely entered into the electronic Clinical Management System (e-CMS) for every consultation by health care professionals, backed up by the Clinical Data Analysis Reporting System (CDARS). Paper records will only be used during rare occasions where computer systems are unexpectedly not operational. These computerized databases thus far consist of seven million patient records, one million annual admissions and 13 million ambulatory visits, with medical research as one of the stated purposes of their implementation [17]. Nevertheless, the usefulness of these clinical electronic databases in Hong Kong for high quality health services research has been little explored [17].

Hypertension is a good example of a common and important condition which can be successfully researched using comprehensive computerized patient records [8, 1821]. The prevalence of hypertension in Hong Kong has been reported to exceed 27% and is one of the most common conditions seen in public health sector [22], comparable to the worldwide figure of 26% [23]. The public health costs of hypertension are substantial [24, 25] and represent an important area of health service research [2630], but there is a paucity of reports on health care utilization patterns of this disease among Chinese patients. In the present study we evaluated the completeness of the demographic and prescription details of patients recorded in the e-CMS database of the HA in Hong Kong. Also we examined the patterns and independent predictors of disease coding using antihypertensive drug prescriptions in primary care as an example.

Methods

Data Source and Subjects

Clinical and demographic information were retrieved from CDARS for all patients who attended HA primary care clinics in the New Territory East (NTE) cluster of Hong Kong, during the period from January 2004 to June 2007. We chose this time period because although e-CMS was initiated in 2000, its implementation was gradual and was severely interrupted by the SARS outbreak in 2003. There was no requirement for doctors to enter the ICPC codes into the CMS until post-SARS, which is also when CDARS became operationalised. Thus January 2004 is the earliest time point for the availability of both CDARS and e-CMS data including ICPC codes.

The NTE cluster serves a population of around 1.3 million in Hong Kong, representing 17.2% of the Hong Kong population [31]. This cluster is further divided into 3 separate regions, namely Shatin, Tai-Po and the North District, from the most urbanized to the most rural regions respectively. Their median monthly household incomes in 2006 were US$2,510, US$2,338 and US$2,078 for these three regions respectively, compared to the Hong Kong-wide figure of US$2,240 [31]. These three regions have similar median ages (38–39 years), comparable with the median age of 39 years for Hong Kong.

Eligible subjects were those having received at least one prescription of antihypertensive drugs in any of these primary care visits. Only visits which result in prescription of antihypertensive drugs were included (hereafter named "antihypertensive drug visits"). Since CDARS does not have disease coding, we further obtained a list of patient identity card (ID) numbers from CMS for various relevant codes of the International Classification of Primary Care (ICPC), including uncomplicated hypertension (K86) and other conditions which could potentially affect the prescription choice of antihypertensive drugs, which we therefore refer to as "exclusion codes" (Table 1). These codes were then merged with the information from CDARS using the patients' ID as the unique identifier. Patients were considered 'coded' if they had at least one relevant ICPC code entered in the CMS during the study period. The study was approved by the NTE cluster of HA, and the Survey and Behavioural Research Ethics Committee, Chinese University of Hong Kong
Table 1

Distribution of International Classification of Primary Care (ICPC) codes among patients with ≥ 1 code (N = 57,041)

ICPC codes

Disease entity

Reasons for exclusion

number

%

K87

Complicated hypertension

The presence of unknown complications may favor or preclude prescription of a particular drug class

3310

5.8%

T90

Diabetes Mellitus

Favors the choice of ACEIs

15560

27.3%

T901

Impaired glucose tolerance

 

353

0.6%

T92

Gout

Contraindication of thiazide diuretics

635

1.1%

T93

Lipid disorders

Favor the exclusion of thiazide diuretics and β-blockers

1186

2.1%

K90

Stroke/cerebrovascular accident

Favor the choice of β-blockers

1920

3.4%

K91

Cerebrovascular disease

 

130

0.2%

K74

Ischemic Heart Disease with angina

 

348

0.6%

K76

Ischemic Heart Disease without angina

 

1099

1.9%

K75

Acute Myocardial Infarction

 

213

0.4%

K77

Heart Failure

Favor the choice of ACEIs

794

1.4%

K84

Heart Disease, other

Favor the choice of β-blockers or ACEIs

168

0.3%

K99

Cardiovascular disease, other

 

113

0.2%

R79

Chronic Bronchitis

Contraindication of β-blockers

436

0.8%

R95

Chronic Obstructive Pulmonary Disease

 

2199

3.9%

R96

Asthma

 

1083

1.9%

U14

Kidney symptoms/complaints

Either favor or a contraindication of ACEIs

312

0.5%

U88

Glomerulonephritis/nephrosis

 

36

0.1%

Y85

Benign Prostatic Hypertrophy

Favor the prescription of α-blockers

2917

5.1%

U78

Benign Neoplasm Urinary Tract

 

30

0.1%

Y79

Benign/unspecified neoplasm, male genital

 

1

0.0%

(ACEIs: Angiotensin Converting Enzyme Inhibitors. There were a total of 46,859 patients (82.1%) Apart from K86 these conditions are influencing factors for antihypertensive drug prescription and were named "exclusion codes"

Variables and Statistical Analysis

All retrieved data were transformed and analyzed by the Statistical Package for Social Sciences (SPSS) version 13.0. The proportions of four distinct, mutually exclusive patient groups were reported. These consist of (1). Those coded with K86 and with exclusion coding ("combined group"); (2). Those coded with K86 without any exclusion coding ("K86-only group"); (3). Those not coded with K86 but with at least one exclusion coding ("Exclusion only group"); and (4). Those without K86 nor any exclusion coding ("Non-coded group"). Among patients with at least one code, the distribution of each coding was studied. The basic demographic and health service characteristics of these different coding groups were compared using χ2 tests of homogeneity and Analysis of Variance (ANOVA) for categorical and continuous variables, respectively. These include patient age, gender, payment status (fee-waivers or service payers), district of residence, service type (general out-patient, Family Medicine Specialist Clinic (FMSC), staff clinics) and appointment type (new or subsequent visits) All these data were routinely entered by clinic staffs when patients attended for consultation, apart from service type. We further analyzed the independent predictors of patients having received at least one ICPC code, as those listed in Table 1, by physicians using bivariate analysis, followed by multivariable analysis by entering predictors with statistically significance into a binary logistic regression equation. A forward stepwise model was adopted and only those significant independent predictors were reported. All p values <0.05 were regarded as statistically significant.

Results

Overall patient breakdown

A total of 1,096,282 antihypertensive drug visits were retrieved from January 2004 to June, 2007, representing 93,450 patients. Demographic and socio-economic details were recorded for all patients. Prescription details for anti-hypertensive drugs were missing in only 18 patients (0.02%), including drug dosage, frequency, or prescription period, and a combination of these. Figure 1 shows the breakdown of disease coding relevant to antihypertensive (anti-HT) drug prescriptions. Relevant ICPC-codes were absent in 36,409 patients (39% of the total sample); i.e., these patients had neither K86 nor any exclusion code. The remaining 57,041 (61% of total) patients had at least one relevant disease identified by an ICPC code. Of these, 46,859 (50.1% of the total sample) had uncomplicated hypertension (K86) coding, and among these K86-coded patients, 16,155 patients (17.2%) also had at least one additional (exclusion) code, resulting in 30,704 patients (32.9% of total) with uncomplicated hypertension (K86) without associated co-morbidity (i.e., no exclusion codes).
Figure 1

The breakdown of disease coding relevant to antihypertensive (anti-HT) drug prescriptions.

Most of the patients were receiving calcium channel blockers (49%) and β-blockers (46%), followed by angiotensin converting enzyme inhibitors (19%) and thiazide diuretics (13%).

Distribution of codes and morbidities

Out of the 57,041 patients (61.0%) with at least one ICPC disease code, the majority (82.1%) had uncomplicated hypertension (K86) followed by diabetes mellitus (T90, 27.3%), complicated hypertension (K87, 5.8%) and benign prostatic hypertrophy (Y85, 5.1%) (Table 1). The coding proportions of other relevant diseases were low. Among patients with at least one coded condition, 66.7% had one code (or one condition) and 27.8% two or more from the list of conditions shown in Table 1. Among patients coded with K86, the figures are similar (65.5% K86 only and 29.5% K86 coded with exclusion codes, respectively).

Comparing patient characteristics among different coding groups

The whole study cohort had an average age of 64 years, with the majority (61.2%) being 60 years old or over (Table 2). Patients with uncomplicated hypertension (K86-only group) had a similar age distribution to the non-coded group. Overall there were more female than male patients (Table 2). The K86-only and non-coded groups had more female patients than the other two groups. Almost half of all patients lived in the Shatin region, which is the most urbanized area in the NTE cluster (Table 2). More patients from the K86-only group lived in the Shatin district than the other groups. The non-coded group had the smallest proportion of patients residing in Shatin (33%).
Table 2

Patient characteristics according to K86 & exclusion coding

Coding

K86 coded & without exclusion codes (n = 30,704)

K86 coded with exclusion codes (n = 16,155)

No K86 but with exclusion codes (n = 10,182)

No K86 & no exclusion codes (36,409)

All cases (n = 93,450)

p value*

Patient

"K86 only group"

"combined group"

"Exclusion group"

"Non-coded group"

  

Age on appt. (no.%)

      

<50

4550(14.8)

1,073 (6.6)

791 (7.8)

7,484 (20.6)

13898(14.9)

<0.001

50–59

8116(26.4)

2,814 (17.4)

1,804 (17.7)

9,704 (26.7)

22438(24.0)

 

60–69

6954(22.6)

4,191(25.9)

2,421 (23.8)

7,516 (20.6)

21082(22.6)

 

≥70

11084(36.1)

8,077 (50.0)

5,166 (50.7)

11,705 (32.1)

36032(38.6)

 

Mean Age on appt . (SD) (95% C.I.)

63.87(13.06)

68.22 (11.61)

68.45 (12.46)

61.77 (14.26)

64.30 (13.51)

<0.001

 

(63.73, 64.02)

(68.04, 68.40)

(68.21, 68.69)

(61.62, 61.91)

(64.21, 64.39)

 

Gender(No./%)

      

Male

11,323 (36.9)

7,442 (46.1)

6,153 (60.4)

15,412 (42.3)

40330 (43.2)

<0.001

Female

19,381 (63.1)

8,713 (53.9)

4,029 (39.6)

20,997 (57.7)

53120 (56.8)

 

Payment status

      

Fee-waivers

7,949 (25.9)

4,379 (27.1)

3,147 (30.9)

9,696 (26.6)

25,171 (26.9)

<0.001

Non- waivers

22,755 (74.1)

11,776 (72.9)

7,035 (69.1)

26,713 (73.4)

68,279 (73.1)

 

District of residence

      

Shatin

18,510 (60.3)

8,817 (54.6)

5,524 (54.3)

12,120 (33.3)

44,971 (48.1)

<0.001

Taipo

6,780 (22.1)

2,883 (17.8)

1,773 (17.4)

11,156 (30.6)

22,592 (24.2)

 

North

4,068 (13.2)

3,721 (23.0)

2,206 (21.7)

10,684 (29.3)

20,679 (22.1)

 

Others

1,346 (4.4)

734 (4.5)

679 (6.7)

2,449 (6.7)

5,208 (5.6)

 

Service type

      

General

28,946 (94.3)

13,881 (85.9)

7,523 (73.9)

34,524 (94.8)

84,874 (90.8)

<0.001

FMSC/IC

1,625 (5.3)

2,260 (14.0)

2,618 (25.7)

1,673 (4.6)

8,176 (8.7)

 

Staff clinic

133 (0.4)

14 (0.1)

41 (0.4)

212 (0.6)

400 (0.4)

 

Appointment type (no./%)

      

New case

14,705 (47.9)

5,485 (34.0)

4,784 (47.0)

23,831 (65.5)

48,805 (52.2)

<0.001

Old case

15,999 (52.1)

10,670 (66.0)

5,398 (53.0)

12,578 (34.5)

44,645 (47.8)

 

(*: Pearson Chi Square tests)

Most patients attended the primary care general out-patient clinics for antihypertensive drugs, but the exclusion group had more patients who attended FMSC. The distribution of service types was similar between the K86-only group and the non-coded group. Overall more than half of the patients were 'new' in terms of antihypertensive drug visits during the study period. The non-coded group had the greatest proportion of new visits (66%), almost twice as high as in the combined group (34.0%).

Factors associated with disease coding

Multi-regression logistic regression was used to determine the independent predictors of disease coding, i.e., the factors associated with whether a patient receiving antihypertensive drugs had an ICPC disease code or not. Younger patients (< 50 years) were less likely to be coded than older patients (Table 3). Female patients were more likely to be coded (aOR = 1.202, 95% C.I. 1.168, 1.238, p < 0.001). Patients living in Shatin district were more likely to receive a code when compared to other less urbanized regions (aOR range from 0.316 to 0.405). Patients visiting family medicine specialist clinics were more likely to be coded when compared to general out-patient clinics (aOR = 1.448, 95% C.I. 1.362, 1.539, p < 0.001). Follow-up cases were more likely to have a code (aOR = 2.394, 95% C.I. 2.324, 2.467, p < 0.001). No significant association was found between payment status and physician coding.
Table 3

Associated factors of coding by physicians

Coding

Coded* (n = 57,041)

Non-coded(n = 36,409)

Adjusted Odds Ratios** (95% C.I.)

p value

Patient

    

Age on appt. (no.%)

    

<50

6,414(11.2)

7,484(20.6)

1.000 (reference)

 

50–59

12,735(22.3)

9,704(26.7)

1.364(1.302, 1.429)

<0.001

60–69

13,566(23.8)

7,516(20.6)

1.774(1.692, 1.861)

<0.001

≥70

24,327(42.6)

11,705(32.1)

2.180(2.088, 2.277)

<0.001

Gender

    

Male

24,918(43.7)

15,412(42.3)

1.000 (reference)

 

Female

32,123(56.3)

20,997(57.7)

1.202(1.168,1.238)

<0.001

Payment status

    

Fee-waivers

15,475(27.1)

9,696(26.6)

  

Payers

41,566(72.9)

26,713(73.4)

Not significant

 

District of residence

    

Shatin

32,851(57.6)

12,120(33.3)

1.000 (reference)

 

Taipo

11,436(20.0)

11,156(30.6)

0.316(0.304, 0.327)

<0.001

North

9,995(17.5)

10,684(29.3)

0.330(0.318, 0.343)

<0.001

Others

2,759(4.8)

2,449(6.7)

0.405(0.381, 0.432)

<0.001

Service type

    

General

50,350(88.3)

34,524(94.8)

1.000 (reference)

 

FMSC

6,503(11.4)

1,673(4.6)

1.448(1.362, 1.539)

<0.001

Staff clinic

188(0.3)

212(0.6)

0.940(0.760, 1.162)

0.565

Appointment type (no./%)

    

New case

24,974(43.8)

23,831(65.5)

1.000 (reference)

 

Old case

32,067(56.2)

12,578(34.5)

2.394(2.324, 2.467)

<0.001

(FMSC: Family Medicine Specialist Clinic. *Coded group refers to patients having at least one code, either K86 or exclusion coding. **represent odds ratios after controlling for all the predictor variables)

Discussion

Main findings

The present study shows that the public clinical databases on antihypertensive drugs in Hong Kong are complete in demographic and socio-economic data, and 99.98% complete in prescription details. Among patients receiving antihypertensive prescription in the primary care system, the proportion having any relevant disease code was relatively modest (61.0%) when compared with other practices in Western countries. About one third (32.9%) of patients were identified as uncomplicated hypertensive (K86-only) patients with no exclusion conditions. There was similarity however between the K86-only group and non-coded groups in age and gender distribution, payment status as well as service types, suggesting that most non-coded patients probably had uncomplicated hypertension. The important independent positive predictors of having an ICPC code were advanced age, female gender, residence in urbanized district, service type being family medicine specialty, and follow-up case.

Interpretation of findings

The completeness of the demographic, socio-economic, and prescribing details relate to the way in which this information is organized and documented within the e-CMS. Patient must register at first attendance and the demographic and socio-economic data is entered directly into the computer system by administrative staff in the reception office. Prescriptions can only be issued via the CMS, including private prescriptions. Thus we would expect such data to be complete. ICPC codes on the other hand are entered by the attending physicians during the consultation. Most primary care clinics are extremely busy (each doctor needs to handle 70–80 patients a day), and short consultations are the norm rather than the exception Thus it is perhaps unsurprising that ICPC codes were often not entered into the e-CMS. Audit work has shown that diagnoses are often entered into the hand written notes rather than given an ICPC code (MCS Wong, unpublished data).

The finding that older patients are more likely to be coded can perhaps be explained by the presence of more morbidities in the elderly group and perhaps more frequent consulting (and hence likelihood of ICPC code being entered on at least one occasion) which would also be the case for the higher coding rates in the follow-up patients. The coding difference in different districts of residence may possibly be explained by the concentration of training centres and teaching clinics in Shatin. The similarly higher coding rate in FMSC can also be explained by the more stringent coding requirement of specialty clinics. That higher likelihood of the female patients receiving a code is also of interest and further exploration of the reasons is needed.

Since completion of the current study, the NTEC, HA has reinforced its ICPC coding policy and the coding rate for all diseases as of July, 2007 has been reported to be 87.7% [information provided by statistics team of the Hospital Authority Head Office, November 2007]. Thus in future work using this database substantially higher percentages of disease coded data for patients with hypertension and other chronic conditions seems likely.

Relationship to published literature

Many studies have used different diseases to validate local databases. For the GPRD database in the UK, hospital investigations and death certificates have been adopted to support the validity of disease codes for deep vein thrombosis and pulmonary embolism [32]. Questionnaires posted to general practitioners have been used to verify the diagnosis and severity of chronic obstructive pulmonary diseases for validation of the OXMIS codes of GPRD [33]. Both studies found good agreement between database disease codes and the tools used for validation, and concluded that GPRD is of sufficiently high quality for epidemiological research. Other methods for database validation include the use of morbidity surveys and national data to compare with database information [34, 35], which reported similar database usefulness. Many studies on GPRD mainly focused on the completeness and quality of computer recorded data [36, 37]. GPRD has been used to address a variety of clinical issues, including pharmaco-epidemiology and medication safety [38], rheumatoid diseases [39, 40], gout [41, 42], diabetes [43], and sexually transmitted infections [44], among others. The GPRD in UK consists of information from practices which are up to standard, requiring the practice to record a minimum of 95% of prescribing and relevant patient-encounter events [45]. Also data from practices are routinely under internal checks for validity [34], and each practice will be sent a validation report after data collection.

We are unaware of any published work on validation of the accuracy of disease codes in the HA e-CMS in Hong Kong, but clearly this would be an important area for future work if more rigorous health services research is planned. However, a first step is the need for implementation of a quality control system and the necessary organizational changes to ensure more complete data entry in terms of ICPC disease codes.

Strengths and weaknesses of current study

The major strength of this study was the availability of a large amount of electronic patient data on antihypertensive medication over a three and a half year period from which we could ascertain the potential and pitfalls of using such data in health services research in the public healthcare system in Hong Kong. We have done this in a systematic way, and included robust statistical analysis to aid interpretation.

However, this study also has some weaknesses. Firstly, there are no external data to support the validity of the database. We regarded the ICPC code as the 'gold standard' in categorizing our study cohort. The accuracy of these codes however, has not been formally validated against data from case notes or those from the secondary care sector (which uses International Classification of Diseases (ICD) codes). However, given the relatively straightforward diagnosis of uncomplicated hypertension we believed the biases may be minimal. Secondly, these data apply only to the NTE cluster, which represents only one of seven organisational units within the HA in Hong Kong. Thus we cannot know if the issues raised in the study apply across the public healthcare system in Hong Kong, although we have no reason to suspect that NTE is different organizationally that other clusters. Thirdly, due to gradual implementation of the e-CMS system and the disruption of SARS in 2003 the present study could not evaluate ICPC coding before 2004, and some of the 'un-coded' patients in the present study could have been coded by physicians pre-2004 into hand-written records or free text space. However, since January 2004, all doctors in the clinics are required to use the computer system as the sole portal of information entry and patients with ICPC codes in hand-written notes or free text before January 2004 should have had that information re-entered into the e-CMS at consultations during the study period. However, the ICPC code need only be entered once to be counted as a 'coded patient' (not re-coded at every consultation).

Implications for policy and practice

Hypertension is an important chronic disease globally and locally in Hong Kong. The large numbers of electronic patient records and completeness of some information could potentially serve to help addressing this condition in important areas of health services research, such as drug prescription profiles and health service utilization patterns. The scale of the database also has potential in clinical epidemiological research with linkage between the needs of the populations served, their geographical location, and the availability of high quality primary care on the basis of such needs. Data protection issues should however be observed by researchers; the present database is anonymized having only identity numbers without patient contact details hence enhancing its data safety. In practical terms, there are simple steps that can be initiated at minimal cost, to enhance the quality of the e-CMS data. For example, guidelines on ICPC coding for the clinical staff may be helpful, and system changes which require the entry of ICPC codes as compulsory rather than optional. Our finding that more family medicine specialist clinics are likely to have coding supports the effectiveness of routine data protocols in enhancing disease coding rates, because these clinics are doctor training centers where data recording protocols are more stringently managed and implemented. Further studies are needed to validate the accuracy and completeness of CDARS and CMS in Hong Kong by more rigorous testing. These include comparison of cluster-representative surveys with data generated for each disease entity to ensure they are representative, and exploration of the disease status of uncoded patients by case-note reviews to test whether the uncoded group is likely to have uncomplicated hypertension only.

Since prescription details are virtually complete, this database has the potential to study the patterns of antihypertensive prescription, profiles of drug discontinuation and switching, and the association of antihypertensive drug class to clinical outcomes like mortality. Work is underway currently on all these areas of enquiry.

Conclusion

The e-CMS database of the HA in Hong Kong varies in quality in terms of recorded information. Potential future health services research using demographic and prescription information is highly feasible but for disease-specific research dependant on ICPC codes some caution is warranted. In the case of uncomplicated hypertension, future research on pharmaco-epidemiology (such as prescription patterns) and clinical issues (such as side-effects of medications on metabolic parameters) seems feasible given the large size of the data set and the comparability of coded and non-coded patients.

Declarations

Acknowledgements

The authors would like to acknowledge the support of the Hospital Authority, Hong Kong and the input by colleagues in the Primary Care research Group of the School of Public Health, Chinese University of Hong Kong for their generous support to this project. SW Mercer conducted this work as Visiting Professor in Primary Care Research at the School of Public Health, Chinese University of Hong Kong.

Authors’ Affiliations

(1)
Department of Community and Family Medicine and School of Public Health, Chinese University of Hong Kong, School of Public Health, Prince of Wales Hospital
(2)
General Practice and Primary Care, Division of Community-Based Sciences, Faculty of Medicine, University of Glasgow

References

  1. Trevisani F, Magini G, Santi V, Morselli-Labate AM, Cantarini MC, Di Nolfo MA, Del Poggio P, Benvegnu L, Rapaccini G, Farinati F, Zoli M, Borzio F, Giannini EG, Caturelli E, Bernardi M, Italian Liver Cancer (ITA.LI.CA) Group: Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. American Journal of Gastroenterology. 2007, 102: 1022-31. 10.1111/j.1572-0241.2007.01100.x.View ArticlePubMedGoogle Scholar
  2. McKeever TM, Lewis SA, Smith C, Hubbard R: The importance of prenatal exposures on the development of allergic disease: a birth cohort study using the West Midlands General Practice Database. American Journal of Respiratory & Critical Care Medicine. 2002, 166: 827-32. 10.1164/rccm.200202-158OC.View ArticleGoogle Scholar
  3. Jones R, Latinovic R, Charlton J, Gulliford MC: Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database. BMJ. 2007, 334: 1040-10.1136/bmj.39171.637106.AE.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Fleming DM, Watson JM, Nicholas S, Smith GE, Swan AV: Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989–90 using a general practice database. Epidemiol Infect. 1995, 115 (3): 581-9.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Gibbs RG, Todd JC, Irvine C, Lawrenson R, Newson R, Greenhalgh RM, Davies AH: Relationship between the regional and national incidence of transient ischemic attack and stroke and performance of carotid endarterectomy. Eur J Vascular Endovascular Surg. 1998, 16: 47-52. 10.1016/S1078-5884(98)80091-9.View ArticleGoogle Scholar
  6. Lawrenson R, Williams T, Farmer R: Clinical information for research; the use of general practice databases. Journal of Public Health Medicine. 1999, 21: 299-304. 10.1093/pubmed/21.3.299.View ArticlePubMedGoogle Scholar
  7. EPIC: EPICGPRD: A guide for researchers. 2003, London: EPICGoogle Scholar
  8. Mazzaglia G, Mantovani LG, Sturkenboom MCJM, Filippi A, Trifiro G, Cricelli C, Brignoli O, Caputi AP: Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens. 2005, 23: 2093-2100. 10.1097/01.hjh.0000186832.41125.8a.View ArticlePubMedGoogle Scholar
  9. Williams JI, Young W: A summary of studies on the quality of health care administrative databases in Canada. Patterns of Health Care in Ontario. The ICES Practice Atlas. Edited by: Goel V, Williams JI, Anderson GM, Blackstein-Hirsh P, Fooks C, Naylor CD. 1996, Ottawa, Canada: Canadian Medical Association, 339-345. 2Google Scholar
  10. Booth GL, Kapral MK, Fung K, Tu JV: Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet. 2006, 368: 29-36. 10.1016/S0140-6736(06)68967-8.View ArticlePubMedGoogle Scholar
  11. Hux JE, Ivis F, Flintoft V, Bica A: Diabetes in Ontario: Determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care. 2002, 25: 512-516. 10.2337/diacare.25.3.512.View ArticlePubMedGoogle Scholar
  12. Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, Olsen J, Melbye M: A population-based study of measles, mumps, and rubella vaccination and autism. New England Journal of Medicine. 2002, 347: 1477-82. 10.1056/NEJMoa021134.View ArticlePubMedGoogle Scholar
  13. Smith GC, Wood AM, Pell JP, White IR, Crossley JA, Dobbie R: Second-trimester maternal serum levels of alpha-fetoprotein and the subsequent risk of sudden infant death syndrome. New England Journal of Medicine. 2004, 351: 978-86. 10.1056/NEJMoa040963.View ArticlePubMedGoogle Scholar
  14. Edgren G, Hjalgrim H, Reilly M, Tran TN, Rostgaard K, Shanwell A, Titlestad K, Adami J, Wikman A, Jersild C, Gridley G, Wideroff L, Nyren O, Melbye M: Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study. Lancet. 2007, 369: 1724-30. 10.1016/S0140-6736(07)60779-X.View ArticlePubMedGoogle Scholar
  15. Capewell S, MacIntyre K, Stewart S, Chalmers JW, Boyd J, Finlayson A, Redpath A, Pell JP, McMurray JJ: Age, sex, and social trends in out-of-hospital cardiac deaths in Scotland 1986–95: a retrospective cohort study. Lancet. 2001, 358: 1213-7. 10.1016/S0140-6736(01)06343-7.View ArticlePubMedGoogle Scholar
  16. Cruz-Correia RJ, Vieira-Marques PM, Ferreira AM, Almeida FC, Wyatt JC, Costa-Pereira AM: Reviewing the integration of patient data: how systems are evolving in practice to meet patient needs. BMC Medical Informatics & Decision Making. 2007, 7: 14-10.1186/1472-6947-7-14.View ArticleGoogle Scholar
  17. Cheung NT: Health informatics, Hospital Authority, Hong Kong. Realizing the benefits of eHealth in Hong Kong. Accessed on 19, September, 2007, [http://www.ehealth.org.hk/Speaker/Dr%20Ngai%20Tseung%20CHEUNG.pdf]
  18. Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP: Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of United Kingdom population. BMJ. 1995, 311: 293-295.View ArticlePubMedPubMed CentralGoogle Scholar
  19. Tu K, Campbell NRC, Duong-Hua M, McAlister FA: Hypertension Management in the Elderly has improved: Ontario Prescribing Trends, 1994 to 2002. Hypertension. 2005, 45: 1113-1118. 10.1161/01.HYP.0000164573.01177.95.View ArticlePubMedGoogle Scholar
  20. Burke TA, Sturkenboom MC, Lu S, Wenworth CE, Lin Y, Rhoads GG: Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. J Hypertens. 2006, 24: 1193-1200. 10.1097/01.hjh.0000226211.95936.f5.View ArticlePubMedGoogle Scholar
  21. Degli EE, Sturani A, Degli EL, Macini PL, Falasca P, Valpiani G, Buda S: Pharmacoutilization of antihypertensive drugs: a model of analysis. International Journal of Clinical Pharmacology & Therapeutics. 2001, 39: 251-8.Google Scholar
  22. Department of Health and Department of Community Medicine, University of Hong Kong. 2004, Population Health Survey, Accessed 08, October, 2007, [http://www.chp.gov.hk/files/pdf/full_report_on_population_health_survey_2003_2004_en_20051024.pdf]
  23. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J: Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004, 22: 11-19. 10.1097/00004872-200401000-00003.View ArticlePubMedGoogle Scholar
  24. Ezzati M, Hoorn Vander S, Lawes CM, Leach R, James WP, Lopez AD, Rodgers A, Murray CJ: Rethinking the "disease of affluence" paradigm: global patterns of nutritional risks in relation to economic development. PloS Med. 2005, 2: e133-10.1371/journal.pmed.0020133.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Hoes AW, Grobbee DE, Lubsen J, Man in 't Veld AJ, Does van der E, Hofman A: Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med. 1995, 123 (7): 481-487.View ArticlePubMedGoogle Scholar
  26. Singh RB, Suh IL, Singh VP, Chaithiraphan S, Laothavorn P, Sy RG, Babilonia NA, Rahman AR, Sheikh S, Tomlinson B, Sarraf-Zadigan N: Hypertension and stroke in Asia: Prevalence, control and strategies in developing countries for prevention. J Hum Hypertens. 2000, 14: 749-763. 10.1038/sj.jhh.1001057.View ArticlePubMedGoogle Scholar
  27. Singh RB, Five City Study Group: Prevalence and risk factors of hypertension and age specific blood pressures in five cities: a study of Indian women. Int J Cardiol. 1998, 63: 165-173. 10.1016/S0167-5273(97)00296-9.View ArticlePubMedGoogle Scholar
  28. Ueshima H, Zhang XH, Choudhury SR: Epidemiology of hypertension in China and Japan. J Hum Hypertens. 2000, 14: 765-69. 10.1038/sj.jhh.1001054.View ArticlePubMedGoogle Scholar
  29. Gupta R: Hypertension in India: definition, prevalence and evaluation. J Indian Med Assoc. 1999, 97: 74-80.PubMedGoogle Scholar
  30. InterASIA Collaborative group: Cardiovascular risk factor levels in urban and rural Thailand: The International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Eur J Cardiovasc Prev Rehabil. 2003, 10: 249-57. 10.1097/00149831-200308000-00006.View ArticleGoogle Scholar
  31. Population by-census, Hong Kong Special Administrative Region, China. 2006, Accessed 09, October, 2007, [http://www.bycensus2006.gov.hk/data/data2/index.htm]
  32. Lawrenson R, Todd J-C, Leydon GM, Williams TJ, Farmer RDT: Validation of the diagnosis of venous thromboembolism in general practice database studies. Br J Clin Pharmacol. 2000, 49: 591-596. 10.1046/j.1365-2125.2000.00199.x.View ArticlePubMedPubMed CentralGoogle Scholar
  33. Soriano JB, Maier WC, Visick G, Pride NB: Validation of general practitioner-diagnosed COPD in the UK General Practice Research Database. European Journal of Epidemiology. 2001, 17: 1075-1080. 10.1023/A:1021235123382.View ArticlePubMedGoogle Scholar
  34. Hollowell J: The General Practice Research Database: quality of morbidity data. Popul Trends. 1997, 87: 36-40.PubMedGoogle Scholar
  35. McCormack A, Fleming D, Caharlton J: Morbidity statistics from general practice. 1995, Fouth national study 1991–92. HMSO, LondonGoogle Scholar
  36. Nazareth I, King M, Haines A, Rangel L, Myers S: Accuracy of diagnosis of psychosis on general practice computer system. BMJ. 1993, 307: 32-34.View ArticlePubMedPubMed CentralGoogle Scholar
  37. Nazareth I, King M, Haines A, See Tai S, Hall G: Care of schizophrenia in general practice. BMJ. 1993, 307: 910.View ArticlePubMedPubMed CentralGoogle Scholar
  38. Hardy JR, Leaderer BP, Holford TR, Hall GC, Bracken MB: Safety of medications prescribed before and during early pregnancy in a cohort of 81,975 mothers from the UK General Practice Research Database. Pharmacoepidemiology & Drug Safety. 2006, 15: 555-64. 10.1002/pds.1269.View ArticleGoogle Scholar
  39. Nightingale AL, Farmer RD, de Vries CS: Incidence of clinically diagnosed systemic lupus erythematosus 1992–1998 using the UK General Practice Research Database. Pharmacoepidemiology & Drug Safety. 2006, 15: 656-61. 10.1002/pds.1199.View ArticleGoogle Scholar
  40. Karopka T, Fluck J, Mevissen HT, Glass A: The Autoimmune Disease Database: a dynamically compiled literature-derived database. BMC Bioinformatics. 2006, 7: 325-10.1186/1471-2105-7-325.View ArticlePubMedPubMed CentralGoogle Scholar
  41. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Saag KG: Supoptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricemia: results from the UK General Practice Research Database (GPRD). Rheumatology. 2005, 44: 1038-42. 10.1093/rheumatology/keh679.View ArticlePubMedGoogle Scholar
  42. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schmacher HR, Saag KG: Gout epidemiology: results from the UK General Practice Research Database, 1990–1999. Annals of the Rheumatic Diseases. 2005, 64: 267-72. 10.1136/ard.2004.024091.View ArticlePubMedPubMed CentralGoogle Scholar
  43. Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM: All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992–1999. Diabetologia. 2006, 49: 660-6. 10.1007/s00125-005-0120-4.View ArticlePubMedGoogle Scholar
  44. Cassell JA, Mercer CH, Sutcliffe L, Petersen I, Islam A, Brook MG, Ross JD, Kinghorn GR, Simms I, Hughes G, Majeed A, Stephenson JM, Johnson AM, Hayward AC: Trends in sexually transmitted infections in general practice 1990–2000: population based study using data from the UK general practice research database. BMJ. 2006, 332: 332-4. 10.1136/bmj.38726.404120.7C.View ArticlePubMedPubMed CentralGoogle Scholar
  45. Walley T, Mantgani A: The UK General Practice Research Database. Lancet. 1997, 350: 1097-99. 10.1016/S0140-6736(97)04248-7.View ArticlePubMedGoogle Scholar
  46. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6963/8/138/prepub

Copyright

© Wong et al; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement